Vita Life Sciences Ltd (VLS) - Total Liabilities
Based on the latest financial reports, Vita Life Sciences Ltd (VLS) has total liabilities worth AU$22.03 Million AUD (≈ $15.59 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Vita Life Sciences Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Vita Life Sciences Ltd - Total Liabilities Trend (2000–2024)
This chart illustrates how Vita Life Sciences Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Vita Life Sciences Ltd.
Vita Life Sciences Ltd Competitors by Total Liabilities
The table below lists competitors of Vita Life Sciences Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aurora World Corporation
KQ:039830
|
Korea | ₩425.37 Billion |
|
Eva Live Inc. Common Stock
NASDAQ:GOAI
|
USA | $7.27 Million |
|
Devsisters corporation
KQ:194480
|
Korea | ₩140.26 Billion |
|
Sunfon Construction Co Ltd
TWO:5514
|
Taiwan | NT$3.94 Billion |
|
Riverview Bancorp Inc
NASDAQ:RVSB
|
USA | $1.33 Billion |
|
Yi Jinn Industrial Co Ltd
TW:1457
|
Taiwan | NT$8.31 Billion |
|
LINMON MEDIA LTD -000025
F:8MN
|
Germany | €832.79 Million |
|
SBI Investment KOREA Co. Ltd
KQ:019550
|
Korea | ₩4.14 Billion |
Liability Composition Analysis (2000–2024)
This chart breaks down Vita Life Sciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Vita Life Sciences Ltd's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.46 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vita Life Sciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vita Life Sciences Ltd (2000–2024)
The table below shows the annual total liabilities of Vita Life Sciences Ltd from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$19.61 Million ≈ $13.87 Million |
+19.02% |
| 2023-12-31 | AU$16.48 Million ≈ $11.66 Million |
+7.71% |
| 2022-12-31 | AU$15.30 Million ≈ $10.82 Million |
+3.02% |
| 2021-12-31 | AU$14.85 Million ≈ $10.51 Million |
+1.27% |
| 2020-12-31 | AU$14.66 Million ≈ $10.37 Million |
+4.88% |
| 2019-12-31 | AU$13.98 Million ≈ $9.89 Million |
+5.00% |
| 2018-12-31 | AU$13.31 Million ≈ $9.42 Million |
+63.13% |
| 2017-12-31 | AU$8.16 Million ≈ $5.77 Million |
-11.14% |
| 2016-12-31 | AU$9.18 Million ≈ $6.50 Million |
-3.45% |
| 2015-12-31 | AU$9.51 Million ≈ $6.73 Million |
+9.26% |
| 2014-12-31 | AU$8.71 Million ≈ $6.16 Million |
+51.67% |
| 2013-12-31 | AU$5.74 Million ≈ $4.06 Million |
+4.92% |
| 2012-12-31 | AU$5.47 Million ≈ $3.87 Million |
+24.54% |
| 2011-12-31 | AU$4.39 Million ≈ $3.11 Million |
-31.17% |
| 2010-12-31 | AU$6.38 Million ≈ $4.52 Million |
+30.01% |
| 2009-12-31 | AU$4.91 Million ≈ $3.47 Million |
+2.38% |
| 2008-12-31 | AU$4.79 Million ≈ $3.39 Million |
+24.56% |
| 2007-12-31 | AU$3.85 Million ≈ $2.72 Million |
-58.89% |
| 2006-12-31 | AU$9.36 Million ≈ $6.62 Million |
-68.51% |
| 2005-12-31 | AU$29.73 Million ≈ $21.04 Million |
+1.80% |
| 2004-12-31 | AU$29.21 Million ≈ $20.67 Million |
+0.97% |
| 2003-12-31 | AU$28.92 Million ≈ $20.47 Million |
+39.80% |
| 2002-12-31 | AU$20.69 Million ≈ $14.64 Million |
-20.03% |
| 2001-12-31 | AU$25.87 Million ≈ $18.30 Million |
+29.32% |
| 2000-12-31 | AU$20.00 Million ≈ $14.15 Million |
-- |
About Vita Life Sciences Ltd
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands… Read more